{
    "clinical_study": {
        "@rank": "165075", 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine the safety of two consecutive days of metyrapone\n      (MRP) in subjects who may use cocaine concurrently."
        }, 
        "brief_title": "Cocaine-Metyrapone Interaction Study - 1", 
        "completion_date": "May 2002", 
        "condition": [
            "Cocaine-Related Disorders", 
            "Infusions, Intravenous"
        ], 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "detailed_description": {
            "textblock": "To evaluate the safety of metyrapone (MRP) for using in an outpatient study in which\n      participants would be given 2 750 mg doses of MRP per week. Secondary study goals are to\n      evaluate the possible efficacy of MRP as a treatment for cocaine dependence and to compare 3\n      factors hypothesized to induce cocaine craving: cocaine cues, stress, and cocaine itself.\n      This study will utilize a Double Blind, placebo-controlled crossover design with 3 factors:\n      1) medication 2) relapse trigger and 3) infusion for an 11 day in-patient treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Male or Females between 18 and 45 yrs of age; cocaine dependence according to DSM-4;\n        females of child-bearing potential must test non-pregnant and use adequate birth control;\n        be able to provide consent, comply with protocol requirements and try to complete all\n        study treatments.\n\n        Exclusion Criteria:\n\n        Additional criteria available during screening at the site."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "12", 
        "firstreceived_date": "April 5, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_alias": "NCT00024778", 
            "nct_id": "NCT00033098", 
            "org_study_id": "NIDA-CTO-0006-1"
        }, 
        "intervention": {
            "intervention_name": "Metyrapone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Metyrapone"
        }, 
        "lastchanged_date": "October 23, 2007", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cincinnati", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "45220"
                }, 
                "name": "Cincinnati VA Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Cocaine-Metyrapone Interaction Study", 
        "overall_official": {
            "affiliation": "Cincinnati VA Medical Center", 
            "last_name": "Theresa Winhusen, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "primary_outcome": {
            "measure": "Cocaine craving"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00033098"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "Cincinnati VA Medical Center", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "November 2001", 
        "study_design": "Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2003"
    }, 
    "geocoordinates": {
        "Cincinnati VA Medical Center": "39.103 -84.512"
    }
}